Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 47,348,207
- Share change
- -6,222,551
- Total reported value
- $399,128,639
- Put/Call ratio
- 14%
- Price per share
- $8.43
- Number of holders
- 129
- Value change
- -$50,141,212
- Number of buys
- 69
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
11%
|
6,776,269
|
$53,600,000 | — | 30 Jun 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
7.7%
|
4,794,499
|
$37,924,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
6.5%
|
4,056,200
|
$32,085,000 | — | 30 Jun 2022 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.9%
|
3,700,608
|
$29,272,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
5.6%
|
3,490,998
|
$27,613,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
3,454,916
|
$27,328,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
2,734,765
|
$21,631,000 | — | 30 Jun 2022 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.9%
|
2,449,183
|
$19,373,000 | — | 30 Jun 2022 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.6%
|
2,260,572
|
$17,881,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
2.8%
|
1,776,438
|
$14,050,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
1.8%
|
1,106,838
|
$8,755,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,089,528
|
$8,618,000 | — | 30 Jun 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1.7%
|
1,065,724
|
$8,430,000 | — | 30 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
1,000,045
|
$7,910,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
852,775
|
$6,745,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
821,921
|
$6,501,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
817,832
|
$6,469,000 | — | 30 Jun 2022 | |
| Finepoint Capital LP |
13F
|
Company |
1.2%
|
735,126
|
$5,815,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
631,916
|
$4,999,000 | — | 30 Jun 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.96%
|
596,487
|
$4,718,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.83%
|
518,400
|
$4,101,000 | — | 30 Jun 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.74%
|
464,057
|
$3,671,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
423,420
|
$3,349,000 | — | 30 Jun 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.62%
|
388,637
|
$3,074,000 | — | 30 Jun 2022 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.59%
|
367,117
|
$2,904,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.54%
|
337,972
|
$2,674,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.52%
|
324,758
|
$2,569,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
322,867
|
$2,554,000 | — | 30 Jun 2022 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.51%
|
320,426
|
$2,535,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.51%
|
317,473
|
$2,511,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.51%
|
315,644
|
$2,497,000 | — | 30 Jun 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.5%
|
314,232
|
$2,486,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.49%
|
307,225
|
$2,430,000 | — | 30 Jun 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.46%
|
289,562
|
$2,289,000 | — | 30 Jun 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.41%
|
257,357
|
$2,036,000 | — | 30 Jun 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.35%
|
219,820
|
$1,739,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.26%
|
164,075
|
$1,298,000 | — | 30 Jun 2022 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.25%
|
153,033
|
$1,210,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
142,071
|
$1,124,000 | — | 30 Jun 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.22%
|
138,395
|
$1,095,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
128,987
|
$1,020,000 | — | 30 Jun 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.2%
|
122,271
|
$967,000 | — | 30 Jun 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.19%
|
121,005
|
$957,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.19%
|
120,495
|
$954,000 | — | 30 Jun 2022 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.19%
|
116,807
|
$923,943 | — | 30 Jun 2022 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.18%
|
114,759
|
$908,000 | — | 30 Jun 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.18%
|
111,126
|
$879,000 | — | 30 Jun 2022 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
99,176
|
$784,000 | — | 30 Jun 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.14%
|
88,578
|
$701,000 | — | 30 Jun 2022 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.14%
|
88,097
|
$697,000 | — | 30 Jun 2022 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2022
As of 30 Sep 2022,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,348,207 shares.
The largest 10 holders included
STATE STREET CORP, RTW INVESTMENTS, LP, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Point72 Asset Management, L.P., JOHNSON & JOHNSON, Bain Capital Life Sciences Investors, LLC, and MORGAN STANLEY.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
125
Q3 2022 holders
129
Holder diff
4
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.